The PE Ratio as of September 2024 (TTM) for BioCardia, Inc. (BCDA) is -0.53

According to BioCardia, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.53. This represents a change of -54.48% compared to the average of -1.16 of the last 4 quarters.

BioCardia, Inc. (BCDA) Historical PE Ratio (quarterly & annually)

How has BCDA PE Ratio performed in the past?

The mean historical PE Ratio of BioCardia, Inc. over the last ten years is -1.84. The current -0.53 PE Ratio has changed 2.77% with respect to the historical average. Over the past ten years (40 quarters), BCDA's PE Ratio was at its highest in in the September 2014 quarter at 13.06. The PE Ratio was at its lowest in in the June 2017 quarter at -25.65.

BioCardia, Inc. (BCDA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BioCardia, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioCardia, Inc. (BCDA) Average PE Ratio

How has BCDA PE Ratio performed in the past?

The current PE Ratio of BioCardia, Inc. (BCDA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BioCardia, Inc. (BCDA) PE Ratio vs. Peers

How is BCDA’s PE Ratio compared to its peers?

BioCardia, Inc.’s PE Ratio is greater than Aerovate Therapeutics, Inc. (-0.63), greater than Adagene Inc. (-3.10), greater than Acrivon Therapeutics, Inc. Common Stock (-4.45), greater than Rezolute, Inc. (-4.50), less than AN2 Therapeutics, Inc. (-0.48), greater than ZIVO Bioscience, Inc. (-2.68), greater than Theseus Pharmaceuticals, Inc. (-3.19), greater than Erasca, Inc. (-3.85), greater than Forte Biosciences, Inc. (-9.46), less than Applied Molecular Transport Inc. (-0.14), greater than ABVC BioPharma, Inc. (-0.68), greater than Indaptus Therapeutics, Inc. (-0.81), less than Pasithea Therapeutics Corp. (-0.25), less than Better Therapeutics, Inc. (-0.00), greater than Anebulo Pharmaceuticals, Inc. (-5.80), greater than Mineralys Therapeutics, Inc. (-4.79), greater than NervGen Pharma Corp. (-8.01), greater than Protagenic Therapeutics, Inc. (-0.54), greater than Miromatrix Medical Inc. (-3.41),

Build a custom stock screener for BioCardia, Inc. (BCDA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioCardia, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioCardia, Inc. (BCDA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioCardia, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.